Volume | 4,076 |
|
|||||
News | - | ||||||
Day High | 5.07 | Low High |
|||||
Day Low | 4.76 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Helius Medical Technologies Inc | HSDT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.94 | 4.76 | 5.07 | 4.98 | 5.075 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
85 | 4,076 | $ 4.96 | $ 20,203 | - | 4.29 - 14.44 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:27:57 | 9 | $ 4.77 | USD |
Helius Medical Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.53M | 708.25k | - | 644k | -8.85M | -12.50 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Helius Medical Technolog... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HSDT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.3996 | 5.41 | 4.76 | 5.21 | 11,472 | -0.4196 | -7.77% |
1 Month | 5.71 | 7.188 | 4.76 | 6.43 | 333,839 | -0.73 | -12.78% |
3 Months | 6.82 | 9.50 | 4.29 | 6.20 | 438,978 | -1.84 | -26.98% |
6 Months | 7.33 | 9.50 | 4.29 | 6.23 | 207,756 | -2.35 | -32.06% |
1 Year | 10.05 | 14.44 | 4.29 | 8.30 | 372,429 | -5.07 | -50.45% |
3 Years | 871.00 | 881.50 | 4.29 | 39.51 | 691,118 | -866.02 | -99.43% |
5 Years | 4,760.00 | 5,792.50 | 4.29 | 336.61 | 559,393 | -4,755.02 | -99.90% |
Helius Medical Technolog... Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. |